4
Changes in Ownership
PDS Biotechnology Corp Filed Acc 0001127602-17-023286
President and CEO sold 7,500 shares at an average $10.19 ($76,400)
From the SEC's structured data for this filing
Trades in this filing
Leuthner Brian A · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-07-03 | Sale : show line 1 in the form | −2,500 | $10.27 | $25,675 | 132,736 | D |
| 2017-07-05 | Sale : show line 2 in the form | −2,500 | $10.21 | $25,525 | 130,236 | D |
| 2017-07-06 | Sale : show line 3 in the form | −2,500 | $10.08 | $25,200 | 127,736 | D |
| Open-market sales · 7,500 sh · avg $10.19 · $76,400 | ||||||
Loading xslF345X03/form4.xml…